This inventor holds 4 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Ariagen, Inc., Huawei Technologies Co., Limited, Other. Active years: 2009-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shanghai, CN (2009 - 2018)
- Shenzhen, CN (2015 - 2023)
Company Filing History:


Years Active: 2009-2023
Title: Guodong Li: Innovator in Pharmaceutical Chemistry
Introduction
Guodong Li is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.
Latest Patents
One of Guodong Li's latest patents involves aryl hydrocarbon receptor modulators. This patent discloses a range of compounds with specific structural formulas that can be used in pharmaceutical applications. Another notable patent details the efficient and scalable synthesis of 2-(1'H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester and its structural analogs. This method includes various condensation reactions to create the thiazoline or thiazole moiety, showcasing his expertise in synthetic chemistry.
Career Highlights
Throughout his career, Guodong Li has worked with several notable companies, including Ariagen, Inc. and Huawei Technologies Co., Limited. His experience in these organizations has allowed him to refine his skills and contribute to various innovative projects in the pharmaceutical sector.
Collaborations
Guodong Li has collaborated with talented individuals such as Suoming Zhang and Jiasheng Song. These partnerships have fostered a creative environment that has led to the development of groundbreaking inventions.
Conclusion
Guodong Li is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile